APA (7th ed.) Citation

C. Schwabe, A. Cole, A. Espigares‐Correa, M. E. Beydon, A. Florez‐Igual, & J. Queiruga‐Parada. (2023). A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab. Wiley.

Chicago Style (17th ed.) Citation

C. Schwabe, A. Cole, A. Espigares‐Correa, M. E. Beydon, A. Florez‐Igual, and J. Queiruga‐Parada. A Randomized, Double‐blind, Single‐dose Study to Assess Bioequivalence of MB02 Biosimilar After Manufacturing Iteration and Reference Bevacizumab. Wiley, 2023.

MLA (9th ed.) Citation

C. Schwabe, et al. A Randomized, Double‐blind, Single‐dose Study to Assess Bioequivalence of MB02 Biosimilar After Manufacturing Iteration and Reference Bevacizumab. Wiley, 2023.